Bath & Body Works, Inc. $BBWI Shares Sold by 111 Capital

111 Capital trimmed its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 73.7% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,905 shares of the company’s stock after selling 22,168 shares during the period. 111 Capital’s holdings in Bath & Body Works were worth $237,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in the business. SVB Wealth LLC purchased a new position in shares of Bath & Body Works in the 1st quarter valued at $35,000. Geneos Wealth Management Inc. increased its holdings in Bath & Body Works by 217.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after purchasing an additional 801 shares in the last quarter. Parallel Advisors LLC increased its holdings in Bath & Body Works by 63.3% in the 2nd quarter. Parallel Advisors LLC now owns 1,241 shares of the company’s stock valued at $37,000 after purchasing an additional 481 shares in the last quarter. Golden State Wealth Management LLC lifted its stake in shares of Bath & Body Works by 94.7% during the first quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company’s stock worth $40,000 after purchasing an additional 642 shares in the last quarter. Finally, UMB Bank n.a. lifted its stake in shares of Bath & Body Works by 65.9% during the first quarter. UMB Bank n.a. now owns 1,501 shares of the company’s stock worth $46,000 after purchasing an additional 596 shares in the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on BBWI shares. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $26.00 target price on shares of Bath & Body Works in a research note on Monday. Citigroup lowered their price objective on shares of Bath & Body Works from $42.00 to $40.00 and set a “buy” rating for the company in a research report on Tuesday, August 19th. Weiss Ratings reissued a “hold (c-)” rating on shares of Bath & Body Works in a research report on Saturday, September 27th. Wall Street Zen downgraded shares of Bath & Body Works from a “buy” rating to a “hold” rating in a research note on Saturday, August 9th. Finally, Barclays lifted their price target on shares of Bath & Body Works from $30.00 to $32.00 and gave the stock an “equal weight” rating in a research note on Friday, August 29th. Eleven analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Bath & Body Works currently has an average rating of “Moderate Buy” and an average target price of $38.15.

Bath & Body Works Trading Up 2.1%

BBWI stock opened at $26.42 on Tuesday. The firm has a 50 day simple moving average of $28.33 and a 200-day simple moving average of $29.43. The company has a market capitalization of $5.45 billion, a P/E ratio of 7.84, a PEG ratio of 0.88 and a beta of 1.52. Bath & Body Works, Inc. has a twelve month low of $24.93 and a twelve month high of $41.87.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings data on Thursday, August 28th. The company reported $0.37 EPS for the quarter, meeting analysts’ consensus estimates of $0.37. The firm had revenue of $1.55 billion for the quarter, compared to the consensus estimate of $1.55 billion. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The firm’s revenue was down .8% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.37 EPS. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. On average, research analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, September 5th. Investors of record on Friday, August 22nd were paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 3.0%. The ex-dividend date was Friday, August 22nd. Bath & Body Works’s dividend payout ratio (DPR) is 23.74%.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.